WELL Health Technologies (TSE:WEL – Get Rating)‘s stock had its “hold” rating reaffirmed by equities research analysts at Desjardins in a research report issued on Sunday, Zacks.com reports. Desjardins also issued estimates for WELL Health Technologies’ FY2022 earnings at $0.21 EPS and FY2023 earnings at $0.32 EPS.
WELL Health Technologies (TSE:WEL – Get Rating) last announced its quarterly earnings results on Thursday, March 31st. The company reported C$0.02 EPS for the quarter, topping analysts’ consensus estimates of C($0.02) by C$0.04. The company had revenue of C$115.68 million during the quarter.
- 3 Analyst Favorite Blue-Chip Stocks to Buy Now
- Does PNC Financial Stock Belong in Your Portfolio?
- Institutional Buying Puts A Bottom In Manpower Group Inc
- Workhorse Johnson & Johnson Plows New All-Time Highs
- Fastenal Stock is Ready to Sprint Higher
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
